CONRIG PHARMA ApS: Financial statements 2015
CVR: 33373236
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -88,540 and a net result of DKK -73,599 compared with DKK -81,341 the year before. Equity amounted to DKK 620,467. The solvency ratio was 96.9%.
- Gross Profit
- -88,540 kr.
- Profit/Loss
- -73,599 kr.
- Equity
- 620,467 kr.
- Total Assets
- 640,446 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -89 t. | -74 t. | 620 t. | - |
| 2014 | - | -93 t. | -81 t. | 94 t. | - |
| 2013 | - | -228 t. | -274 t. | 276 t. | - |
| 2012 | - | -266 t. | -244 t. | 200 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of November 24, 2015, John Bondo Hansen has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Niels Skjærbæk has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Mikael Søndergaard Thomsen has joined the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Frank Knudsen has left the board of directors of CONRIG PHARMA ApS.
As of November 24, 2015, Else Sissel Vorstrup has left the board of directors of CONRIG PHARMA ApS.
As of November 23, 2015, John Bondo Hansen has left the board of directors of CONRIG PHARMA ApS.
CONRIG PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -92,788, and the net result was DKK -81,341.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees. In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity amounted to DKK 0.
